ClinicalTrials.gg
Enrolling by invitationNCT04954638Updated Oct 31, 2022

The Effectiveness of Hyperpure Chlorine Dioxide and Sodium Hypochlorite Irrigants in Endodontic Retreament in RCT

An observational study in Persistent Infection and Periapical Lesion, sponsored by Eniko Vaszine Szabo. Enrolling by invitation at 1 site in Hungary. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2022-10-31.

Sponsored by Eniko Vaszine Szabo · Observational

From the registry’s dates

  • Primary completion was expected by Jul 2023, 3 years 3 months ago, but the record still lists the study as enrolling by invitation.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
40
Ages
18 Years to 65 Years
Sex
All
01

Study summary

Endodontic treatment aims to eliminate pathogenic microbes from the root canal. Hyperpure chlorine dioxide is an endodontic irrigant. Our goal is to compare the efficacy of hyperpure chlorine dioxide with the gold standard sodium hypochlorite in the non-surgical retreatment of root canal treated teeth with chronic periapical lesions in a randomized clinical trial. Forty patients having chronic apical periodontitis will randomly be chosen for the study from the patients attending our Department of Conservative Dentistry. Endodontic treatment will be done according to professional quidelines. The patients will randomly be divided into two groups. In the first (control) group sodium hypochlorite, in the second group hyperpure chlorine dioxide will be used as desinfectant. The first sample will be taken from the root canal after removing the previous root canal obturation prior to desinfection. The second sample will be taken one week after temporization. The samples will be evaluated by culturing, MALDI-ToF and PCR strip test. After root canal obturation the the periapical status will be followed by clinical evaluation and control x-rays.

Read the detailed description

Endodontic treatment aims to eliminate pathogenic microbes from the root canal. This is an almost impossible task as microbes, especially Enterococci are able to line the dentin tubules that are nearly unaccessable to desifectants used during treatment. Hyperpure chlorine dioxide is an endodontic irrigant. In vitro studies proved it to be a very potent desinfectant against which bacteria do not produce resistency. It selectively binds to three amino acids targeting bacterial cells. Due to its small molecular weight and its highly volatile characteristics we presume that it is able to penetrate into the small dentin tubuli. There have been many in vitro studies comparing its characteristics and efficacy, but there have been no in vivo studies done to approve its clinical preformance so far. Our goal is to compare the efficacy of hyperpure chlorine dioxide with the gold standard sodium hypochlorite in the non-surgical retreatment of root canal treated teeth with chronic periapical lesions in a randomized clinical trial. Its efficacy will be compared by microbiological methods and by clinical and radiological evaluation. According to our hypothesis hyperpure chlorine dioxide is more effective antimicrobial agent than the gold standard sodium hypochlorite. The protocol for this clinical study was approved by the Hungarian National Ethics Committee for clinical trials. Forty patients having chronic apical periodontitis will randomly be chosen for the study from the patients attending our Department of Conservative Dentistry. Written consent will be collected from the patients. Only those patients will be accepted who had the root canal treatment done more than four years ago, the tooth is asymptomatic, functionally and esthetically restorable, the coronal restoration can be done within 3-4 weeks of the root canal obturation, who will not have prosthetic or orthodontic treatment interfering with the radiological follow-up and have no general medical conditions or medication influencing the healing of the periapical lesion. Endodontic treatment will be done according to professional quidelines. After sterilizing the tooth and its environment, a sterility test will be be done by taking samples from the top of the restoration (S1) and from the pulp chamber (S2). The root canal obturation will be removed mechanically and a microbiological sample will be taken from the root canal (M1). After taking the sample from the root canal the tooth will be chemomechanically prepared. The patients will randomly be divided into two groups. In the first (control) group sodium hypochlorite, in the second group hyperpure chlorine dioxide will be used as desinfectant. The sample taking procedure will be repeated after one week of temporization (sterility tests S3, S4 and root canal sample M2). The samples will be cultured and identified by MALDI-ToF MS. The remaining samples will be used for PCR testing (Micro-IDent Plus11, Hain Lifescience) to determine the presence of the tested bacteria. In the second session the root canal obturation will be completed. Following coronal restoration a control x-ray will be done by using an individual bite-block for standardization. The success of the root canal treatment will be followed-up by evaluating the periapical status with the Periapical Index scoring system and clinical evaluation according to the criteria set by the European Society of Endodontology including pain assessment where the patients rate pain on the VNRS, with 0 = ''no pain'' to 10 = ''worst pain imaginable". Clinical evaluation and control x-rays will be done at 6 months, 1, 2, 3, and 4 years following treatment. The x-rays will be evaluated by two blinded calibrated examiners.

02

Conditions studied

  • Persistent Infection
  • Periapical Lesion

Browse trials for

Keywords

  • hyperpure chlorine dioxide
  • sodium hypochlorite
03

In context

Persistent Infection

44 studies on the registry are indexed under Persistent Infection; 5 are open to participants now.

This study's planned enrollment of 40 is below the median of 150 across 15 observational studies indexed under Persistent Infection.

Browse Persistent Infection studies →

Lead sponsor

This is the only study on the registry with Eniko Vaszine Szabo as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

patients attending the clinic

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • patients having asymptomatic chronic apical periodontitis of size 4-5 according to periapical index scoring system

Exclusion criteria

Exclusion Criteria:

  • patients who suffer from diabetes, osteoporosis, cancer, autoimmue disease
  • patients who are in immune suppressed state
  • patients receiving , bisphosphonate, denosumab or antiangiogenic therapy
  • alcoholism
  • smoking
  • patients having had antibiotic therapy in the past 4 weeks before starting treatment
  • teeth with furcation involvement
  • teeth with deeper than 4 mm probing depth or the same on neighboring teeth
  • patients intending to undergo prosthodontic or orthodontic treatment within four years
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Corticosteroids (steroids)

Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.

Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
40 participants (estimated)
Patient registry
No
Biospecimen retention
Samples with dna

Groups and cohorts

  • sodium hypochlorite

    group 1: control group with sodium hypochlorite desinfection

    Other: endodontic desinfection

  • hyperpure chlorine dioxide

    group 2: study group with hyperpure chlorine dioxide desinfection

    Other: endodontic desinfection

Interventions

  • Otherendodontic desinfection

    * outcome assessment of the retreatment of endodontically treated teeth presenting chronic apical periodontitis * effectiveness of hyperpure chlorine dioxide compared with sodium hypochloride * using microbiological methods * outcome assessed by radiological method and clinical evaluation

    Also known as: hyperpure chlorine dioxide, sodium hypochlorite

06

What researchers measure

Primary outcomes

  1. Microbiological assessment

    The presence of bacteria will be assessed in microbiological samples will be taken from the root canal prior to root canal desinfection after removing obturation and one week after desinfection before obturation. They will be quantified by culturing and specified by MALDI ToF MS. The same samples will be used for PCR strip test to spcify certain test bacteria.

    Time frame: 4 years

  2. Radiological assessment

    After coronal restoration is completed a control x-ray will be taken by means of an individual bite-block. The periapical status will be assessed at the time of obturation-restoration, 6 months, 1, 2, 3, 4 years following endodontic treatment. The outcome will be determined according to the Periapical Index scoring system. The teeth will be evaluated according to healed, healing or unsuccessful as outcome.

    Time frame: 4 years

  3. Clinical evaluation

    At each control appointments a clinical evaluation will be done according to the criteria set by the European Society of Endodontology including: presence of fistula and/or swelling, functionality.

    Time frame: 4 years

  4. Clinical evaluation

    pain evaluated by visual analogue scale

    Time frame: 4 years

07

Study locations

1 site
  • Semmelweis University, Dental Faculty, Conservative Dentistry Department
    Budapest, 1088, Hungary
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 31, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT04954638
Lead sponsor
Eniko Vaszine Szabo
Responsible party
Eniko Vaszine Szabo (principal investigator, Semmelweis University) — Sponsor-investigator
First posted
Jul 8, 2021
Start date
Nov 15, 2019
Primary completion
Jul 31, 2023 (estimated)
Completion
Jul 31, 2025 (estimated)
Last update
Oct 31, 2022

Study contacts

Enikő Vasziné Szabó, DMD PhD
principal investigator · Semmelweis University
Zsolt Lohinai, DMD PhD
study director · Semmelweis University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion